Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Couple Charged for Stealing IP from Hospital to Launch Their Own Biotech in China

A San Diego couple, formerly of Ohio, was charged by the federal government with stealing intellectual property related to pediatric medical treatments from Nationwide Children’s Hospital in order to launch a pharmaceutical company in China.

Read More »

Prostate drug may be useful for Parkinson’s disease

Collaborating researchers at the University of Iowa and Capital Medical University in China found that a drug used to treat enlarged prostate, terazosin, appears able to slow the progress of Parkinson’s disease.

Read More »

Sanofi Reports Strong Second-Quarter 2019

Sanofi reported overall net sales increased by 5.5 percent for second-quarter 2019, driven by Sanofi Genzyme, Sanofi Pasteur and emerging markets.

Read More »

AstraZeneca raises 2019 sales forecast after second-quarter cancer drug, China boost

AstraZeneca Plc raised the company’s product sales forecast for 2019 after second-quarter results beat analysts’ expectations, thanks to strong sales from cancer medicines and emerging markets, especially China.

Read More »

China Has Big Presence in Top 10 Biotech IPOs in 2019

New rules went into effect during 2018 on the Hong Kong stock exchange allowing companies that did not have a product on the market or generate revenue to list on the exchange.

Read More »

Neuroscientists at Emory University Terminated Following Scrutiny of Chinese Funding Ties

Emory University in Georgia fired a husband and wife neuroscience research team after they were accused of failing to disclose ties to China that included financial funding.

Read More »

Newer drugs fuel AstraZeneca Q1 2019 sales beat

AstraZeneca Plc beat first-quarter 2019 sales and earnings expectations as the British drugmaker benefited from a push into cancer drugs and emerging markets including China.

Read More »

Bayer looking into established drugs strategy

Bayer is looking into future options for the established drugs business, partly because of price pressure in China, the German company’s head of pharmaceuticals said.

Read More »

Eli Lilly Sells Two Legacy Drugs and Manufacturing Facility for $375 Million

Lilly inked a deal with Eddingpharm for the rights to two legacy antibiotic medicines and a manufacturing facility in Suzhou, China.

Read More »

MD Anderson Ousts Three Scientists Over Intellectual Property Theft Concerns

MD Anderson Cancer Center has dismissed three scientists who have been associated with espionage conducted by the Chinese government. Two other scientists are also under scrutiny, the Houston Chronicle reported.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom